Evaluation of Efficacy and Safety of Ponatinib as Third-line Treatment in Patients with the Diagnosis of Chronic Phase Chronic Myeloid Leukemia
-
Published:2016-12-30
Issue:4
Volume:26
Page:224-226
-
ISSN:1306-133X
-
Container-title:International Journal of Hematology and Oncology
-
language:
-
Short-container-title:UHOD
Publisher
Akademi Doktorlar Yayinevi
Subject
Oncology,Hematology